« Back to Record
Ponde, N., Bradbury, I., Lambertini, M., Ewer, M. S., Campbell, C., Ameels, H., Zardavas, D., Di Cosimo, S., Baselga, J., Huober, J., Izquierdo, M., Fumagalli, D., Bozovic-Spasojevic, I., Maetens, M. M., Harbeck, N., Pusztai, L., Berghorn, M., Im, Y. H., Borrego, M. R., Chen, D.-R., Rodeheffer, R., Piccart-Gebhart, M., Suter, T., & de Azambuja, E. (2017). Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast cancer research and treatment. doi:10.1007/s10549-017-4628-3
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265787



